Hamilton Thorne Ltd
XTSX:HTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Hamilton Thorne Ltd
Income from Continuing Operations
Hamilton Thorne Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hamilton Thorne Ltd
XTSX:HTL
|
Income from Continuing Operations
$1.9m
|
CAGR 3-Years
34%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Income from Continuing Operations
$2.9B
|
CAGR 3-Years
61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Income from Continuing Operations
$1.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Income from Continuing Operations
$3.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Income from Continuing Operations
$6.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Income from Continuing Operations
$2.9B
|
CAGR 3-Years
29%
|
CAGR 5-Years
22%
|
CAGR 10-Years
17%
|
|
Hamilton Thorne Ltd
Glance View
Hamilton Thorne Ltd. engages in the provision of laboratory instruments, consumables, software and services to the assisted reproductive technology (ART) and developmental biology research markets. The company is headquartered in Beverly, Massachusetts. The company went IPO on 2007-07-10. The firm's products lines include precision laser devices, imaging systems, micromanipulation systems, air purification systems, incubators, control rate freezers, and lab monitoring systems. Its GM501 product provides the In Vitro Fertilization (IVF)lab with a cell culture media solution, including oocyte handling, sperm processing, embryo culture, and cryopreservation. Its services offers a range of user needs, ranging from equipment service contract and maintenance programs, quality control testing services to manufacturers of medical devices, culture media and consumables used in IVF labs, and laboratory design and installation services. The firm's brands include Hamilton Thorne, Gynemed, Planer, IVFtech, Embryotech Laboratories, and Tek-Event.
See Also
What is Hamilton Thorne Ltd's Income from Continuing Operations?
Income from Continuing Operations
1.9m
USD
Based on the financial report for Dec 31, 2022, Hamilton Thorne Ltd's Income from Continuing Operations amounts to 1.9m USD.
What is Hamilton Thorne Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-20%
Over the last year, the Income from Continuing Operations growth was -22%. The average annual Income from Continuing Operations growth rates for Hamilton Thorne Ltd have been 34% over the past three years , -20% over the past five years .
